News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
455,780 Results
Type
Article (23098)
Company Profile (126)
Press Release (432552)
Multimedia
Podcasts (114)
Webinars (9)
Section
Business (145684)
Career Advice (562)
Deals (23324)
Drug Delivery (82)
Drug Development (62002)
Employer Resources (56)
FDA (11027)
Job Trends (8942)
News (221474)
Policy (17260)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (1302)
Academic (1)
Accelerated approval (56)
ADA (42)
Adcomms (27)
Allergies (118)
Alliances (29873)
ALS (198)
Alzheimer's disease (1455)
Antibody-drug conjugate (ADC) (486)
Approvals (11461)
Artificial intelligence (481)
ASCO (289)
Autoimmune disease (338)
Automation (36)
Bankruptcy (171)
Best Places to Work (7504)
BIO (58)
BIOSECURE Act (13)
Biosimilars (167)
Biotechnology (102)
Bladder cancer (192)
Brain cancer (78)
Breast cancer (734)
Cancer (5721)
Cardiovascular disease (438)
Career advice (498)
Career pathing (11)
CAR-T (392)
CDC (15)
Celiac Disease (2)
Cell therapy (1086)
Cervical cancer (39)
Clinical research (56079)
Collaboration (1823)
Company closure (5)
Compensation (1013)
Complete response letters (77)
COVID-19 (1407)
CRISPR (115)
C-suite (1042)
Cystic fibrosis (143)
Data (7524)
Decentralized trials (1)
Denatured (18)
Depression (160)
Dermatology (81)
Diabetes (521)
Diagnostics (3954)
Digital health (35)
Diversity (4)
Diversity, equity & inclusion (17)
Drug discovery (277)
Drug pricing (106)
Drug shortages (23)
Duchenne muscular dystrophy (300)
Earnings (58727)
Editorial (36)
Employer branding (11)
Employer resources (58)
Events (78153)
Executive appointments (905)
FDA (14326)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (22)
Frontotemporal dementia (34)
Funding (1462)
Gene editing (245)
Generative AI (41)
Gene therapy (863)
GLP-1 (834)
Government (1971)
Grass and pollen (1)
Guidances (327)
Healthcare (11777)
Hematology (179)
HIV (71)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (103)
Immunology and inflammation (263)
Immuno-oncology (102)
Indications (190)
Infectious disease (1596)
Inflammatory bowel disease (194)
Inflation Reduction Act (5)
Influenza (54)
Intellectual property (225)
Interviews (70)
IPO (11884)
IRA (21)
Job creations (1759)
Job search strategy (439)
JPM (49)
Kidney cancer (21)
Labor market (35)
Layoffs (344)
Leadership (14)
Legal (3603)
Liver cancer (85)
Longevity (25)
Lung cancer (765)
Lymphoma (465)
Machine learning (39)
Management (16)
Manufacturing (835)
Marketing (3)
MASH (188)
Medical device (7638)
Medtech (7738)
Mergers & acquisitions (12470)
Metabolic disorders (1340)
mRNA (161)
Multiple sclerosis (171)
NASH (16)
Neurodegenerative disease (429)
Neuropsychiatric disorders (99)
Neuroscience (2897)
Neurotech (1)
NextGen: Class of 2026 (3544)
Non-profit (1979)
Now hiring (22)
Obesity (613)
Opinion (188)
Ovarian cancer (217)
Pain (212)
Pancreatic cancer (297)
Parkinson's disease (357)
Partnered (28)
Patents (454)
Patient recruitment (683)
Peanut (44)
People (39951)
Pharmaceutical (27)
Pharmacy benefit managers (13)
Phase 1 (17425)
Phase 2 (25000)
Phase 3 (18967)
Pipeline (8403)
Policy (179)
Postmarket research (1832)
Preclinical (6774)
Press Release (69)
Prostate cancer (305)
Psychedelics (69)
Radiopharmaceuticals (316)
Rare diseases (1146)
Real estate (3102)
Recruiting (24)
Regulatory (16330)
Reports (25)
Research institute (1491)
Resumes & cover letters (77)
Rett syndrome (44)
RNA editing (25)
RSV (37)
Schizophrenia (156)
Series A (262)
Series B (196)
Service/supplier (4)
Sickle cell disease (112)
Special edition (18)
Spinal muscular atrophy (158)
Sponsored (33)
Startups (2233)
State (1)
Stomach cancer (15)
Supply chain (77)
Tariffs (41)
The Weekly (94)
Vaccines (520)
Venture capital (90)
Weight loss (375)
Women's health (70)
Worklife (2)
Date
Today (10)
Last 7 days (319)
Last 30 days (1579)
Last 365 days (24298)
2026 (13323)
2025 (23889)
2024 (26743)
2023 (29806)
2022 (37927)
2021 (40339)
2020 (35896)
2019 (27329)
2018 (20519)
2017 (20765)
2016 (18856)
2015 (22820)
2014 (16931)
2013 (13333)
2012 (14037)
2011 (14422)
2010 (13831)
Location
Africa (330)
Alabama (62)
Alaska (3)
Arizona (191)
Arkansas (6)
Asia (26069)
Australia (4080)
California (10809)
Canada (3155)
China (1331)
Colorado (370)
Connecticut (497)
Delaware (347)
Europe (57978)
Florida (1578)
Georgia (314)
Hawaii (2)
Idaho (35)
Illinois (747)
India (96)
Indiana (444)
Iowa (16)
Japan (520)
Kansas (88)
Kentucky (38)
Louisiana (43)
Maine (65)
Maryland (1149)
Massachusetts (8438)
Michigan (229)
Minnesota (580)
Mississippi (3)
Missouri (135)
Montana (21)
Nebraska (18)
Nevada (123)
New Hampshire (49)
New Jersey (3008)
New Mexico (20)
New York (2837)
North Carolina (1487)
North Dakota (10)
Northern California (5626)
Ohio (321)
Oklahoma (16)
Oregon (24)
Pennsylvania (2234)
Puerto Rico (10)
Rhode Island (32)
South America (491)
South Carolina (35)
Southern California (4159)
Tennessee (154)
Texas (1685)
United States (38446)
Utah (272)
Vermont (1)
Virginia (243)
Washington D.C. (42)
Washington State (961)
West Virginia (3)
Wisconsin (131)
Wyoming (2)
455,780 Results for "biotie therapies corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
June 26, 2026
·
4 min read
Press Releases
Trenchant Technologies Capital Corp. Announces Private Placement Offering of up to $1 Million Convertible Debentures
July 6, 2026
·
4 min read
Press Releases
Zenith Capital Corp. Amends Promissory Notes
May 12, 2026
·
6 min read
Press Releases
Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery.
Combining human iPSC biology and AI computing to accelerate drug discovery, improve drug safety, and advance precision medicine.
June 19, 2026
·
1 min read
Press Releases
NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University
June 9, 2026
·
4 min read
Press Releases
Resverlogix Corp. Announces Issuance of MCTO by ASC
April 2, 2026
·
4 min read
Press Releases
Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
April 16, 2026
·
2 min read
Press Releases
CORRECTION FROM SOURCE: Entheon Biomedical Corp. Issues Correction to News Release Dated June 9, 2026
June 10, 2026
·
1 min read
Press Releases
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
April 21, 2026
·
5 min read
Press Releases
OS Therapies Third Quarter 2026 Corporate Outlook
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 3-year overall survival data combined with biomarkers to support early market access
July 6, 2026
·
11 min read
1 of 45,578
Next
